DIVAMICS is an AI- and molecular-dynamics-driven drug discovery platform that combines a proprietary BioTrajectory AI with physics-based multi-scale MD simulations to model protein dynamics and support hit-to-preclinical candidate discovery.
Published Aug 28, 2026
| Starting Price | Not public (controlled access; contact vendor) | Not public for enterprise platform; training and course pricing listed publicly | Partnership-based services; pricing not public |
| Most appropriate for | Teams seeking MD-driven mechanistic insight for flexible or dynamic targets; collaboration-based discovery engagements | Organizations seeking a mature physics-based modeling software stack with enterprise deployment options | Biopharma partners seeking an AI-led discovery partner for pipeline generation |
| Key strength | Emphasis on protein dynamics and a hybrid AI + multi-scale MD modeling approach | Mature platform ecosystem, long-standing presence in computational chemistry | Industrialized AI discovery pipelines and partnership experience |
| Key weakness | Limited independent public reviews and incomplete public security/compliance documentation; access and pricing opaque | Can be complex to deploy and may require significant training and expertise | Partnership model rather than self-serve; pricing and outcomes depend on engagement execution |
—